Canada's biotechnology sector is maturing, with strong science now matched by translational ambition and manufacturing capacity. This development is crucial as it helps convert scientific discoveries into scalable domestic businesses, supported by government initiatives and increased venture capital. Key players like AbCellera are leading the way in translating research into commercial success, setting a precedent for other firms to follow.
Read the full article at Digital Journal
Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.
5
Ali NematiWritten by Ali
